Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008.

Mehmedic Z, Chandra S, Slade D, Denham H, Foster S, Patel AS, Ross SA, Khan IA, ElSohly MA.

J Forensic Sci. 2010 Sep;55(5):1209-17. doi: 10.1111/j.1556-4029.2010.01441.x.

PMID:
20487147
2.

Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication.

Balster RL, Prescott WR.

Neurosci Biobehav Rev. 1992 Spring;16(1):55-62. Review.

PMID:
1313164
3.

Chemical constituents of marijuana: the complex mixture of natural cannabinoids.

Elsohly MA, Slade D.

Life Sci. 2005 Dec 22;78(5):539-48. Epub 2005 Sep 30. Review.

PMID:
16199061
4.

Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis.

Cascini F, Aiello C, Di Tanna G.

Curr Drug Abuse Rev. 2012 Mar;5(1):32-40. Review.

PMID:
22150622
5.

Fungal biotransformation of cannabinoids: potential for new effective drugs.

Saxena S.

Curr Opin Drug Discov Devel. 2009 Mar;12(2):305-12. Review. Erratum in: Curr Opin Drug Discov Devel. 2009 Jul;12(4):562.

PMID:
19333876
6.
7.

Cannabis potency and contamination: a review of the literature.

McLaren J, Swift W, Dillon P, Allsop S.

Addiction. 2008 Jul;103(7):1100-9. doi: 10.1111/j.1360-0443.2008.02230.x. Epub 2008 May 20. Review.

PMID:
18494838
8.

Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?

Seely KA, Prather PL, James LP, Moran JH.

Mol Interv. 2011 Feb;11(1):36-51. doi: 10.1124/mi.11.1.6. Review.

9.

Cannabinoids in clinical practice.

Williamson EM, Evans FJ.

Drugs. 2000 Dec;60(6):1303-14. Review.

PMID:
11152013
10.

Synthetic cannabinoids as drugs of abuse.

Ashton JC.

Curr Drug Abuse Rev. 2012 Jun;5(2):158-68. Review.

PMID:
22530798
11.

A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.

Potter DJ.

Drug Test Anal. 2014 Jan-Feb;6(1-2):31-8. doi: 10.1002/dta.1531. Epub 2013 Sep 30. Review.

PMID:
24115748
12.

Doors of deception: the diaspora of designer drugs.

Kerwin J.

Drug Test Anal. 2011 Sep;3(9):527-31. doi: 10.1002/dta.302. Review. No abstract available.

PMID:
21960538
13.

[Effect and occurrence of synthetic cannabinoids].

Tuv SS, Strand MC, Karinen R, Øiestad EL, Christophersen AS, Vindenes V.

Tidsskr Nor Laegeforen. 2012 Oct 30;132(20):2285-8. doi: 10.4045/tidsskr.12.0471. Review. Norwegian.

14.

Cannabis 1988. Old drug, new dangers. The potency question.

Mikuriya TH, Aldrich MR.

J Psychoactive Drugs. 1988 Jan-Mar;20(1):47-55. Review.

PMID:
3292744
15.

An Overview of Products and Bias in Research.

Gloss D.

Neurotherapeutics. 2015 Oct;12(4):731-4. doi: 10.1007/s13311-015-0370-x. Review.

Supplemental Content

Support Center